Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.7000
-0.0104 (-1.46%)
At close: Jun 27, 2025, 4:00 PM
0.6780
-0.0220 (-3.14%)
After-hours: Jun 27, 2025, 7:59 PM EDT

Immunic Market Cap

Immunic has a market cap or net worth of $67.07 million as of June 27, 2025. Its market cap has decreased by -39.47% in one year.

Market Cap
67.07M
Enterprise Value
53.74M
1-Year Change
-39.47%
Ranking
Category
Stock Price
$0.70

Market Cap Chart

Since April 17, 2014, Immunic's market cap has decreased from $253.40M to $67.07M, a decrease of -73.53%. That is a compound annual growth rate of -11.19%.

History

DateMarket Cap% Change
Jun 26, 202568.00M-24.53%
Dec 31, 202490.10M33.09%
Dec 29, 202367.70M23.09%
Dec 30, 202255.00M-78.11%
Dec 31, 2021251.20M-20.71%
Dec 31, 2020316.80M222.94%
Dec 31, 201998.10M1,141.77%
Dec 31, 20187.90M-96.85%
Dec 29, 2017251.10M80.13%
Dec 30, 2016139.40M-60.23%
Dec 31, 2015350.50M-41.04%
Dec 31, 2014594.50M134.61%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 698.51B
Johnson & Johnson 366.18B
AbbVie 327.76B
Novo Nordisk 313.40B
UnitedHealth Group 277.24B
Abbott Laboratories 240.24B
Novartis AG 232.39B
AstraZeneca 218.32B
Market Cap Rankings